Dr. Van Deventer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Manning Dr
Chapel Hill, NC 27514Phone+1 984-974-0000Fax+1 984-974-8608
Education & Training
- University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 1997 - 2000
- University of MichiganResidency, Internal Medicine, 1993 - 1997
- Virginia Commonwealth University School of MedicineClass of 1993
Certifications & Licensure
- NC State Medical License 1997 - 2025
- MI State Medical License 1996 - 2000
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- 42 citationsPhase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia.Joshua F. Zeidner, Benjamin G. Vincent, Anastasia Ivanova, Dominic T. Moore, Karen P. McKinnon
Blood Cancer Discovery. 2021-09-10 - 16 citationsSafety and Efficacy of Pembrolizumab Prior to Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia.Nicholas Tschernia, Vaibhav Kumar, Dominic T. Moore, Benjamin G. Vincent, Catherine C. Coombs
Transplantation and Cellular Therapy. 2021-08-30 - 14 citationsGenomic Characteristics and Prognostic Significance of Co-mutated ASXL1/SRSF2 Acute Myeloid LeukemiaDaniel R. Richardson, David M Swoboda, Dominic T. Moore, Steven M Johnson, Onyee Chan
American Journal of Hematology. 2021-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: